A randomized, placebo-controlled study of givosiran in patients with acute hepatic porphyrias (ENVISION): Final (36-month) analysis of the Taiwan Cohort. uri icon

authors

  • Lee, Ming-Jen
  • Kuo, Hung-Chou
  • Lin-Na Chou
  • Sweetser, Marianne T
  • Wang, Jiaan-Der

publication date

  • December 2, 2023